A report on pharmacists with the NCMP credential
- PMID: 35486950
- DOI: 10.1097/GME.0000000000001942
A report on pharmacists with the NCMP credential
Abstract
Objective: To characterize the demographics and practices of pharmacists with The North American Menopause Society Certified Menopause Practitioner (NCMP) credential.
Methods: A cross-sectional electronic survey was disseminated to pharmacists with the NCMP credential in June 2018. Twenty-four items were posed to respondents regarding demographics, educational background, and employment, in addition to perspectives regarding the utility of the credential in practice. The questions consisted of multiple choice, as well as open-ended responses.
Results: Of the 40 pharmacists who were invited to participate, 26 (65%) responded. The majority of respondents were women (84%), practicing for at least 10 years (range 5-47 y), based in Canada (70%), and practicing in the community (43%) or compounding (39%) pharmacies. Most pharmacists reported pursuing the credential for credibility with patients (81%), to increase their knowledge about menopause (77%), and for credibility with other healthcare providers (73%). Almost all (88%) plan to renew their credential. Among these pharmacists, many are presently counseling about treatment options (78%) and educating about selected treatment (78%). Pharmacists are most interested in initiating systemic hormonal therapy (61%) and modifying or continuing systemic hormonal therapy (57%).
Conclusions: Pharmacists find the NCMP credential to be valuable. Although pharmacists are engaged in counseling and recommendations, they desire prescriptive authority related to menopause care. Future studies should explore the various pharmacist care models and evaluate the impact of pharmacist care on organizational operations and patient outcomes.
Copyright © 2022 by The North American Menopause Society.
Conflict of interest statement
Financial disclosure/conflicts of interest: S. R. is a speaker for TherapeuticsMD and is a Clinical Advisory Board member for Afaxys Inc. V. P. V. received past funding from American Pharmacists Association and Purdue University. The other authors have no conflicts of interest to disclose.
References
-
- Manson JE, Kaunitz AM. Menopause management - getting clinical care back on track. New Eng J Med 2016; 374:803–806.
-
- Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause 2015; 22:260–266.
-
- IHS Markit Ltd. Association of American Medical Colleges. 2018 update: the complexities of physician supply and demand: projections from 2016 to 2030 final report. Available at: https://aamc-black.global.ssl.fastly.net/production/media/filer_public/8... . Accessed January 13, 2019.
-
- Knapp KK, Paavola FG, Maine LL, Sorofman B, Politzer RM. Availability of primary care providers and pharmacists in the United States. J Am Pharm Assoc (Wash) 1999; 39:127–135.
-
- Centers for Disease Control. Ambulatory care use and physician office visits. Available at: https://www.cdc.gov/nchs/fastats/physician-visits.htm . Accessed January 13, 2019.
MeSH terms
LinkOut - more resources
Full Text Sources